Navigation Links
vivo in Biological Technology

NeurogesX Reports Second Quarter 2009 Results

... of acetaminophen, have been evaluated in in vivo and in vitro preclinical studies and have ... protectant, has been evaluated in vitro and in vivo . Equivalent dose levels of NGX-1576 in mice ... has been evaluated in proof of concept in vivo and in vitro preclinical studies for its ...

VisEn Launches New Cat-K FAST(TM) Fluorescence Molecular Imaging Agent

... VisEn Medical Inc., a leader in fluorescence in vivo imaging from research through medicine, ... disease progression and therapeutic response in vivo . Cathepsin K expression is well known as a key ... ("Fluorescent Activatable Sensor Technology") in vivo agent platform. FAST agents are based on ...

Celsense, Inc Receives NIH Grant to Translate Cell Imaging Technology for Clinical Use

... visible by MRI. Therapeutic cells are labeled ex vivo with the Cell Sense reagent prior to ... used to safely and efficiently label cells ex vivo without the use of transfection agents. Labeled ... region of interest. It is expected that in vivo cellular imaging will routinely be used to ...

Trubion Announces Acceptance of Three Presentations on Its TRU-016 Product Candidate at the 2009 ASCO Annual Meeting

... doxorubicin in killing NHL cells in vitro. In vivo results show that treatment with the combination ... of TRU-016 and bendamustine displayed greater in vivo anti-tumor activity than either agent alone ... molecule therapeutics, and shows significant in vivo efficacy in combination with bendamustine add to ...

NeurogesX Reports First Quarter 2009 Results

... of acetaminophen, have been evaluated in in vivo and in vitro preclinical studies and ... protectant, has been evaluated in vitro and in vivo . Equivalent dose levels of NGX-1576 in mice ... has been evaluated in proof of concept in vivo and in vitro preclinical studies for its ...

AEterna Zentaris Presents Two Posters on its PI3K Inhibitor Compound, AEZS-126, at AACR Annual Meeting

... In Vitro and In vivo Data Show AEZS-126 as Promising Oral Compound for ... safety profiling of the compound, as well as in vivo pharmacokinetic experiments and mouse xenograft ... and cardiac ion-channels. During the course of in vivo pharmacokinetic experiments and mouse xenograft ...

VisEn Launches Next-Generation Fast ('Fluorescence Activatible Sensor Technology') Agent Platform for Expanded Performance in Imaging Disease Biomarkers In Vivo

... VisEn Medical Inc., a leader in fluorescence in vivo imaging from research through medicine, ... biomarkers and drug response in vivo . Newly developed by VisEn Medical, FAST ... and monitoring of key disease biomarkers in vivo . The new MMPSense 750 FAST , the first of the ...

VisualSonics to Sell Mauna Kea Technologies' Cellvizio(R) LAB on a Worldwide Basis to Animal Imaging Market

... market and sell Cellvizio LAB high resolution in vivo imaging systems to pre-clinical researchers on a ... where it offers a unique capability to couple in vivo and in situ observations of neuronal activity on ... system, we can offer researchers more in vivo imaging platforms: our existing family of high ...

EPA Presents Initial Results from Caliper Life Sciences' ToxCast Screening Effort

... data on a broad set of compounds for which in vivo (animal) safety data already existed. Key goals ... establish that the database was predictive of in vivo toxicity profiles. Initial analyses of the data ... the in vitro results generated at CDAS and in vivo toxicity parameters have already been identified. ...

Eiger BioPharmaceuticals Raises $7.1 Million 'A' Round

... A financing co-led by InterWest Partners and vivo Ventures. The two firms were instrumental in the ... investing partners in Menlo Park. About vivo Ventures vivo Ventures ( http://www.vivoventures.com ) is a ...

The IN VIVO Blog Selects First Annual 'Deal of the Year'

... Jan. 8 /PRNewswire/ -- The readers of The IN vivo Blog , which provides news, insights and analysis ... finish among the 13 nominees selected by The IN vivo Blog's writers and editorial team at ... of how the nominees were selected for The IN vivo Blog's Deal of the Year and some commentary from ...

Sigma-Aldrich Introduces MISSION(R) In VIVO QUALITY and iScale Oligos(TM) siRNA, a Superior Quality siRNA Designed for RNAi Research in Animal Models

... today the global release of MISSION(R) In vivo QUALITY and iScale Oligos(TM) siRNA. MISSION(R) In vivo QUALITY and iScale Oligos(TM) siRNA are expected ... an siRNA that is capable of facilitating in vivo siRNA research, with the purity levels required ...

VisEn Announces Commercial Launch of IntegriSenseTM Fluorescence Molecular Imaging Agent

... VisEn Medical, Inc., a leader in fluorescence in vivo imaging from research through medicine, ... in vivo. IntegriSense is an optimized in vivo fluorescence imaging agent targeting integrin ... The agent was developed to enable in vivo imaging of integrin alpha v beta 3 expression in ...

SuperGen Reports 2008 Second Quarter Financial Results

... inhibitor, demonstrated an improved in vivo activity profile over decitabine (Abstract No. ... as a Dinucleotide prodrug increases its in vivo efficacy due to enhanced drug delivery and ... molecule PIM kinase inhibitor with in vivo oral availability and activity in cell ...

AngioGenex Appoints New CEO to Direct Development of Anti-Cancer Drugs

... promising results in both in vitro and in vivo preclinical studies. These data prove that these ... the clinic. The data from the in vitro and in vivo studies not only validate our screening strategy ... is proceeding with a number of additional in vivo studies including tests in tumor models," ...

SemBioSys announces first quarter 2008 financial and operational results

... events include: - Completion of in vivo efficacy studies of cholesterol mobilization ... Apo AI(Milano) - Completion of in vivo efficacy studies of plaque remodeling with ... Apo AI(Milano) upon receiving the initial in vivo efficacy results In addition to its ...

Increased Light Leads to Early Detection: Caliper Life Sciences Introduces Bioware(R) Ultra Cancer Cell Lines

... Able to Detect a Single Cancer Cell Through In vivo Imaging- ... tumor cell lines created specifically for in vivo imaging applications. Bioware Ultra cell lines ... cell in an animal via non-invasive in vivo imaging. Visualizing and tracking tumor ...

ARIUS presents new findings for anti-cancer antibody programs at AACR

... potent anti-tumor efficacy in in vivo models of pancreatic, breast and AML cancers and ... activity and exhibits potent in vivo efficacy in multiple human cancer models. ... This antibody has demonstrated significant in vivo anti-tumor activity towards a broad range of high ...

SemBioSys announces 2007 financial and operational results

... for SemBioSys in 2008. We also expect in vivo functional and efficacy results from Apo ... models. - Demonstrated with in vitro and in vivo assay studies that the Company's ... events include: - Completion of in vivo efficacy studies of cholesterol mobilization ...

ARIUS announces fourth quarter and year-end fiscal 2007 financial results

... tumor growth inhibitory activity in in vivo animal models of breast, prostate, liver, and AML ... binding characteristics and potent in vivo activity. - Preparing to perform preclinical ... antibody to kill cancer stem cells in an in vivo model using cells from human leukemia ...

The Dark Report and Siemens Introduce the World's First Integrated Molecular Summit

... Molecular Summit on the integration of in vivo and in vitro diagnostics on February 5-6, 2008, ... world's first and pre-eminent leader in in vivo and in vitro diagnostics About the Summit The ... Molecular Summit on the integration of in vivo and in vitro diagnostics. Conference attendees ...

CRi Announces Maestro 2, the Next Generation in Vivo Optical Imaging Systems

... of Molecular Imaging joint conference for in vivo imaging, and at the Stanford University Small ... and features of the original Maestro in vivo imaging system with advanced animal handling ... 950 nm, covering the full range of available in vivo fluorophores. The fully automated system allows ...

AEterna Zentaris to Further Develop Three Follow-up Multi-targeted Cytotoxic Candidates to AEZS-112 as Potential Novel Cancer Treatment

... thus demonstrating suitability for in vivo efficacy studies; - Interference with clonogenic ... basis for selection of the most appropriate in vivo efficacy models. Based on their interesting in ... will be subjected to human tumor xenograft in vivo models aimed at selecting an AEZS-112 follow-up ...

Vivo Ventures Expands Team with the Addition of James Huang as an Executive in Residence

... PALO ALTO, Calif., Oct. 24 /PRNewswire/ -- vivo Ventures, a venture capital firm specializing in ... to Vivo," said Frank Kung, Managing Partner of vivo Ventures. "His extensive relationships throughout ... at the University of California, Berkeley. About vivo Ventures ...

VisEn Medical Raises $7 Million in Series B Financing

... in Fluorescence In vivo Imaging-- WOBURN, Mass., Oct. 23 /PRNewswire/ -- VisEn Medical, Inc., a leader in fluorescence in vivo imaging from research through medicine, ... a clear leadership position in fluorescence in vivo imaging, a field of growing importance in the ...

Caliper Life Sciences Awarded National Institute of Environmental Health Services Contract Valued to $7.0 Million

... of the agreement, Xenogen Biosciences, the in vivo drug discovery services arm of Caliper Discovery ... and Xenogen Biosciences, a provider of in vivo discovery services. NovaScreen was acquired by ... CDAS provides a wide range of in vitro and in vivo products and services that enable biotechnology ...

Arpida Invited to Present Preclinical Data on Novel Topical Antibiotic AR-2474 at ICAAC

... laboratories on the promising in vitro and in vivo activity of AR-2474 against panels of bacteria ... to preclinical proof of concept. In two in vivo models, a preliminary topical formulation of ... An additional compound, AR-2474, has achieved in vivo proof of concept. AR-2474 has been shown to be ...

Arius Features Preclinical Data on Antibody Candidates at Two Conferences

... therapeutic in breast cancer models both in vivo and in vitro. The poster also highlights the ... system, is a potent therapeutic in various in vivo cancer models. Arius has demonstrated that its ... complement activity and exhibits potent in vivo efficacy in multiple human cancer models" and ...

VisEn Medical Files Action to Invalidate New Caliper Life Sciences Patent

... apply, and expand their use of fluorescence in vivo imaging from pre-clinical research through ... '851 patent relate to basic methods in optical in vivo imaging. However, prior to the July 1994 priority ... advances, in the field of optical in vivo imaging, including the use of: (i) light- ...

Champions Biotechnology Partners with Do-Coop Technologies to Advance Its Novel Oncology Compound Into Biomerk Tumorgraft(TM) Testing

... Protein Tau) deficient tumors. In both in vitro and in vivo models, SG410 has demonstrated promising activity against prostate and ... allowing researchers to use the same delivery system from in vitro to in vivo research, avoiding a key factor in late-stage failure. Biotech companies ...

EUCODIS Bioscience Signs Research Agreement With Genencor

... Bioscience will apply its proprietary, patent-protected technology of "in vivo recombination" to the development of an optimized version of an ... of commercial enzymes and for industrial partners - our technology of in vivo recombination has reliably shown its capacity to generate high-quality ...

Caliper Life Sciences Reports First Quarter 2009 Results

... from a decrease in in vitro services revenues partially offset by in vivo services revenue improvement. The Company anticipates revenue from CDAS ... innovating new technology to bridge the gap between in vitro assays and in vivo results and then translating those results into cures for human disease. ...

CEL-SCI's L.E.A.P.S. Technology Shows Potential to Treat Swine Influenza in Preclinical Studies

... a similar manner as seen to isolated murine and human dendritic cells ex vivo and in vivo in the mouse. Dendritic cells direct the subsequent immune response to a ...

Keryx Biopharmaceuticals Presents Encouraging Preclinical Data at Annual Meeting of the American Association of Cancer Research

... single agent, inhibits neuroblastoma tumor cell growth in in vitro and in vivo preclinical models. Author(s): Zhijie Li, Fei Tan, Jenna Tong, Amy ... inhibition of Akt phosphorylation, and decreases of cell survival. In vivo studies of perifosine treatment led to significant increases in ...

LNA-Based RNA oligonucleotides Potently Inhibit Cancer microRNAs

... Santaris Pharma announced today promising findings on the in vitro and in vivo activity of microRNA-targeted therapeutics against cancer developed on the ... Locked Nucleic Acid (LNA) Drug Platform. In both in vitro and in vivo models Santaris Pharma's cancer targeted LNA-antimiR(R)'s demonstrated ...

Psylin Neurosciences Commences Development of Compound for Depression

... the predictive power of PsychoGenics' proprietary, high throughput, in vivo approach to drug discovery," said Emer Leahy, Ph.D., Co-CEO of Psylin and ... proprietary drug discovery technologies combine its broad in vivo behavioral expertise with recent developments in robotics, computer ...

AEterna Zentaris To Present Data on Anticancer Compounds AEZS-112 and AEZS-126 at AACR Annual Meeting

... focuses on ADMET and safety profiling of the compound, as well as in vivo pharmacokinetic experiments and mouse xenograft antitumor studies. ... characteristics of this compound that led to its selection for in vivo development. Both posters will be presented on Tuesday, April 21, ...

Sequella Receives SBIR Funding Grant from the NIH for Further Development of Tuberculosis Drug SQ609

... enable Sequella to perform IND-directed preclinical in vitro and in vivo potency, pharmacology, and toxicity studies of SQ609, both as a single ... activity against Mycobacterium tuberculosis in vitro and in vivo , SQ609 has demonstrated synergistic activity with several front-line ...

VisualSonics and Seno Medical Instruments Sign Exclusive Opto-Accoustic Licensing Agreement for Preclinical Research

... is the world's leading developer of high-resolution, ultrasound-based, in vivo micro-imaging systems designed specifically for non-invasive preclinical ... Only VisualSonics platforms combine high-resolution, real-time in vivo imaging with ease-of-use, portability and no negative biological effects. ...

Oncolytics Biotech Inc. Announces 2008 Third Quarter Results

... of two preclinical studies which demonstrated synergy in vitro and in vivo with the combination of REOLYSIN(R) and chemotherapy; - Results ... patent, which covers methods of selectively removing cancer cells ex vivo from blood stem cells and other organs using reovirus; and, - ...
Other Contents
(Date:7/9/2014)... healthy women differ from bacteria in women with ... from Loyola University Chicago Stritch School of Medicine. ... in the American Society for Microbiology,s online journal ... play a role in female urinary health. , ... poorly understood, condition with symptoms similar to urinary ...
(Date:7/9/2014)... the Spanish National Cancer Research Centre (CNIO) have discovered ... also regulates cell division in stratified epitheliathose that form ... the oesophagus or the vaginain adult organisms. According to ... Nature Communications , this factor could also play ... stratified epithelia of the oesophagus and skin. , The ...
(Date:7/9/2014)... Researchers studying critically ill children with traumatic injuries ... patients are likely to develop a hospital-acquired infection. ... Hospital and published online in June in the ... larger efforts that could lead to the clinical ... to prevent or reverse immune system damage following ...
Breaking Biology News(10 mins):CNIO scientists discover that pluripotency factor NANOG is also active in adult organisms 2Immune function predicts infection risk among child trauma patients 2Immune function predicts infection risk among child trauma patients 3
(Date:7/9/2014)... that sudden, acute episodes of low back pain are ... air pressure, wind direction and precipitation. Findings published in ... the American College of Rheumatology (ACR), indicate that the ... wind speed or wind gusts, but was not clinically ... (WHO) nearly everyone experiences low back pain at some ...
(Date:7/9/2014)... was associated with a small increased risk of prostate ... prostate cancer according to a new study from Harvard ... the association remained even among men who received regular ... cannot be explained by diagnostic bias. It is the ... at the link between vasectomy and prostate cancer. , ...
(Date:7/9/2014)... Susan Wakulich was told she had an aneurysm, she figured ... her. , "I was devastated," said Wakulich, who is 56 ... this was a serious diagnosis. Then I met Dr. Bernard ... a less invasive procedure. It was something I didn,t even ... a multi-center U.S. clinical trial to evaluate the safety and ...
(Date:7/9/2014)... Using an innovative tool that captures heretofore hidden ways ... identified a protein that makes breast cancer cells more ... to trigger cancer,s spread in part by blocking two ... finding that suggests these two disease processes could have ... the July 10 issue of Nature , points ...
(Date:7/9/2014)... scientific research into the metabolism of stromal support cells ... metabolism of these cell types in the development of ... inflammatory conditions and cancer. That was the conclusion of ... Leuven in the leading journal Nature . , ... of wake-up call. The metabolism of cancer cells has ...
Breaking Medicine News(10 mins):Health News:Low back pain? Don't blame the weather 2Health News:Vasectomy may increase risk of aggressive prostate cancer 2Health News:New type of stent could help some brain aneurysm patients 2Health News:Protein pushes breast cancer cells to metastasize 2Health News:Protein pushes breast cancer cells to metastasize 3Health News:Wake-up call for more research into cell metabolism 2
Other TagsOther Tags